Keros Therapeutics Market Sentiment

Keros Therapeutics Inc

KROSNASDAQ

$11.43

0.0950.84%

Ult. Agg.: Oct 27, 4:00 PM

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Confronta Opzioni Rapporto azionario

Keros Therapeutics Market Sentiment - Benzinga

Keros Therapeutics Market Sentiment

Market sentiment signals for Keros Therapeutics (KROS): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 6.7% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

18 analysts

Options Flow (P/C)

—

Avg Consensus PT

$26

+123.5%

Highest Price Target

$77

+574.0%

B of A Securities

Lowest Price Target

$15

+31.3%

Piper Sandler

Short Interest

6.7%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 4, 2026	Wells Fargo	Benjamin Burnett—	+57.5%	$20 → $18	Maintained	Overweight
Aug 4, 2026	Leerink Partners	——	+101.3%	$30 → $23	Maintained	Outperform
Mar 5, 2026	Wells Fargo	Benjamin Burnett—	+75.1%	$23 → $20	Maintained	Overweight
Nov 28, 2025	B of A Securities	Jason Zemansky—	+66.3%	$18 → $19	Maintained	Neutral
Nov 12, 2025	Oppenheimer	Andreas Argyrides—	+136.3%	$23 → $27	Maintained	Outperform
Nov 11, 2025	Wells Fargo	Benjamin Burnett—	+101.3%	$26 → $23	Maintained	Overweight
Nov 6, 2025	Wedbush	Yun Zhong—	+40.0%	$15 → $16	Maintained	Neutral
Aug 8, 2025	HC Wainwright & Co.	Andres Y. Maldonado—	+75.1%	$25 → $20	Maintained	Buy
Jun 10, 2025	B of A Securities	Jason Zemansky—	+57.5%	$32 → $18	Downgrade	Buy→Neutral
May 30, 2025	Wedbush	Yun Zhong—	+31.3%	$15 → $15	Maintained	Neutral
May 12, 2025	Scotiabank	Greg Harrison—	+127.6%	$41 → $26	Maintained	Sector Outperform
May 8, 2025	HC Wainwright & Co.	Andrew Fein—	+118.8%	$40 → $25	Maintained	Buy
Apr 9, 2025	Truist Securities	Srikripa Devarakonda—	+118.8%	$43 → $25	Maintained	Buy
Apr 1, 2025	Wedbush	Yun Zhong—	+31.3%	$15 → $15	Maintained	Neutral
Apr 1, 2025	HC Wainwright & Co.	Andrew Fein—	+250.1%	$40 → $40	Maintained	Buy
Feb 27, 2025	Wells Fargo	Tiago Fauth—	+127.6%	$28 → $26	Maintained	Overweight
Feb 27, 2025	HC Wainwright & Co.	Andrew Fein—	+250.1%	$47 → $40	Maintained	Buy
Jan 21, 2025	Cantor Fitzgerald	Prakhar Agrawal—	—	—	Downgrade	Overweight→Neutral
Jan 17, 2025	Piper Sandler	Joseph Catanzaro—	+31.3%	$40 → $15	Maintained	Overweight
Jan 17, 2025	Wedbush	Andreas Argyrides—	+31.3%	$47 → $15	Downgrade	Outperform→Neutral
Jan 17, 2025	Guggenheim	Vamil Divan—	—	—	Maintained	Neutral
Jan 16, 2025	Scotiabank	Greg Harrison—	+258.9%	$44 → $41	Maintained	Sector Outperform
Jan 16, 2025	Oppenheimer	Andreas Argyrides—	+101.3%	$63 → $23	Maintained	Outperform
Dec 23, 2024	Truist Securities	Srikripa Devarakonda—	+276.4%	$100 → $43	Maintained	Buy
Dec 16, 2024	Oppenheimer	Andreas Argyrides—	+451.4%	$102 → $63	Maintained	Outperform